The HIV Vaccine Trials Network (HVTN) Laboratory Center is part of an international collaboration of scientists and educators searching for effective and safe vaccines. The HVTN’s mission is to facilitate the process of testing preventive vaccines against HIV/AIDS and related infectious diseases. The organization conducts all phases of clinical trials from evaluating experimental vaccines for safety and the ability to stimulate immune responses through to testing vaccine efficacy. The Laboratory Center is responsible for carrying out the scientific agenda of the HVTN by conducting laboratory based studies to evaluate the immunogenicity of investigational vaccines.
The Cape Town HVTN Immunology Laboratory (CHIL; www.chil.org.za), a division of the Hutchinson Centre Research Institute of South Africa (HCRISA), performs standardized endpoint assays compliant with GCLP guidelines to analyze immune responses elicited to HIV vaccines in clinical trials. The laboratory is a state-of-the art facility located in the Gardens neighborhood of central Cape Town.
This position will be based in Durban, South Africa